Full Length Research Paper
References
|
Acurcio FA, Silva AL, Ribeiro AQ, Rocha NP, Silveira MR, Klein CH, Rozenfeld S (2009). Complexity of therapeutic regimens prescribed for elderly retirees, Belo Horizonte/MG, Brazil. Rev. Assoc. Med. Bras. 55(4):468-474. crossref |
||||
|
Aguiar PM, Balisa-Rocha BJ, Brito GC, Lyra Jr DP (2012). Pharmaceutical care program for elderly patients with uncontrolled hypertension. J. Am. Pharm. Assoc. 52:515-518. crossref |
||||
| Balisa-Rocha BJ, Aguiar PM, Cerqueira KS, Novaes MB, Alcântara TS, Lyra Junior DP (2014). Evaluation of the effects of long-term of pharmacotherapeutic follow-up intervention on clinical and humanistic outcomes in diabetes mellitus patients. Afr.J. Pharm. Phamacol. 8(14):372-8. view | ||||
| Bachmann KA [et al] (2006). Drug Interactions: the new stardard for drug interactions and herbal. 2.ed. Barueri, SP: Manole. 887p. | ||||
|
Ben AJ, Neumann CR, Mengue SS (2012). The Brief Medication Questionnaire and Morisky-Green Test to evaluate medication adherence. Rev. Saude Pub. 46(2):279-289. crossref |
||||
|
Borges APS, Guidoni CM, Freitas O, Pereira RLR (2011). Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arq. Bras. Endocrinol. Metab. 55(9):686-689. crossref |
||||
|
Castro MS, Fuchs FD, Santos MC, Maximiliano P, Gus M, Moreira LB, Ferrreira MBC (2006). Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-blind clinical trial with ambulatory blood pressure monitoring. Am. J. Hypertens. 19(5):528-553. crossref |
||||
| Chaillet P (2014). Prescription Checker versão 1.3.1/07-2014. Application available in Apple Store. | ||||
|
Chisholm-Burns MA, Graff Zivin JS, Lee JK, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, Abraham I, Palmer J (2010). Economic effects of pharmacists on health outcome in the United States: A systematic review. Am. J. Health-Syst. Pharm. 67 (19):1624-1634. crossref |
||||
|
Cho SJ, Kim J (2014). Factors associated with nonadherence to antihypertensive medication. Nurs. Health Sci. 16(4):461-467. crossref |
||||
|
Chua SS, Kok LC, Yusof FAM, Tang GH, Lee SWH, Efendie B, Paraidathathu T (2012). Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings. BMC Health Serv. Res. 12:388-397. crossref |
||||
|
Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R (2011). Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int. J. Clin. Pharm. 33(2):273-280. crossref |
||||
|
Devold HM, Furu K, Skurtveit S, Tverdal A, Falch JA, Sogaard AJ (2012). Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway. Pharmacoepidemiol. Drug Saf. 21:297–304. crossref |
||||
|
Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D (2013). Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study. Res. Social. Adm. Pharm. 9:797–805. crossref |
||||
| GIAF-UGR (2007). Third consensus of granada on drug related problems (DRP) and negative outcomes associated with medication (NOM). Comite de Consenso GIAF-UGR, GIFAF-USE, GIF-UGR. Ars Pharm. 48(1):5-17. | ||||
|
Gujral G, Winckel K, Nissen LM, Cottrell WN (2014). Impact of community pharmacist intervention discussing patients' beliefs to improve medication adherence. Int. J. Clin. Pharm. 36:1048–1058. crossref |
||||
|
Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV (2015). Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl. J. Med. 372(23):2197-2206. crossref |
||||
|
Hiligsmann M, Boonen A, Rabenda V, Reginster JY (2012). The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Rev. Pharmacoecon. Outcomes Res. 12(2):159–166. crossref |
||||
|
Huri Z, Ling C (2013). Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health. 13:1192. crossref |
||||
| IBGE (2011). Brazilian Institute of Geography and Statistics, Synopsis of the Census 2010. Rio de Janeiro. 261p. | ||||
|
Jódar-Sánchez F, Martín JJ, del Amo MPL, García L, Araújo-Santos JM, Epstein D (2014). Cost-utility analysis of a pharmacotherapy follow-up for elderly nursing home residents in Spain. J. Am. Geriatrics Soc. 62(7):1272-1280. crossref |
||||
|
Kadam UT (2011). Potential health impacts of multiple drug prescribing for older people: a case-control study. Br. J. Gen. Pract. 61:128–310. crossref |
||||
|
Laliberté F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS (2012). Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Adv. Ther. 29(8):675–690. crossref |
||||
|
Lee JK, Grace KA, Taylor AJ (2006). Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 296(21):2563-2571. crossref |
||||
|
Lowrie R, Johansson L, Forsyth P, Bryce SL, McKellar S, Fitzgerald N (2014). Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure. Int. J. Clin. Pharm. 36:154–162. crossref |
||||
|
Lyra Jr DP, Rocha CE, Abriata JP, Gimenes FR, Gonzalez MM, Pelá IR (2007). Influence of Pharmaceutical Care intervention and communication skills on the improvement of pharmacotherapeutic outcomes with elderly Brazilian outpatients. Pat Educ Couns. 68(2): 186–192. crossref |
||||
| Lyra Jr DP, Marcellini PS, Pelá IR (2008). Effect of pharmaceutical care intervention on blood pressure of elderly outpatients with hypertension. Braz. J. Pharm. Sci. 44(3):451. | ||||
| Machuca M, Fernández-Llimós F, Faus MJ (2003). Dader Method. Manual of Pharmacotherapeutic Follow-up. 3rd edition. | ||||
|
Mansoor SM, Aslani P, Krass I (2014). Pharmacists' attitudes and perceived barriers to provision of adherence support in Australia. Int. J. Clin. Pharm. 36:136–144. crossref |
||||
|
Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M (2011). Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. Am. J. Health-Syst. Pharm. 68:241-253. crossref |
||||
|
Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM (2012). Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet. Med. 29:682–689. crossref |
||||
|
Pittman DG, Tao Z, Chen W, Stettin GD (2010). Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am. J. Manag. Care 16(8):568-576. Pubmed |
||||
|
Plaster CP, Melo DT, Boldt V, Cassaro KOS, Lessa FCR, Boechat GAP (2012). Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Braz. J. Pharm. Sci. 48(3):435-446. crossref |
||||
|
Scotti L, Baio G, Merlino L, Cesana G, Mancia G, Corrao G (2013). Cost-effectiveness of enhancing adherence to therapy with blood pressure–lowering drugs in the setting of primary cardiovascular prevention. Value Health. 16:318-324. crossref |
||||
| Silva AS, Rocha Filho JA, Bastos LL, Santana DP, Wanderley AC (2013). Pharmacotherapeutic monitoring of simvastatin-treated patients with dyslipidemia in the Specialized Component of Pharmaceutical Care: a pilot study. Rev. Clin. Pharm. Bás. Apll. 34(1):51-57. | ||||
|
Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA (2011). Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes. Diabetes Care 34:20-26. crossref |
||||
|
Sirey JA, Greenfield A, Weinberger MA, Bruce ML (2013). Medication beliefs and self-reported adherence among community-dwelling older adults. Clin. Ther. 35:153-160. crossref |
||||
|
Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno H Jr (2007). Effect of pharmaceutical care on blood pressure control and health related quality of life in patients with resistant hypertension. Am. J. Health Syst. Pharm. 64(18):1955-1961. crossref |
||||
|
Stewart K, George J, Mc Namara KP, Jackson SL, Peterson GM, Bereznicki LR, Gee PR, Hughes JD, Bailey MJ, Hsueh YSA, McDowel JM, Bortoletto DA, Lau R. (2014). A multifaceted pharmacist intervention to improve antihypertensive adherence: A cluster-randomized, controlled trial (Happy trial). J. Clin. Pharm. Ther. 39:527–534. crossref |
||||
|
Venturini CD, Engroff P, Ely LS, Zago LFA, Schroeter G, Gomes I, De Carli GA, Morrone FB (2011). Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics. 66(11):1867-1872. Pubmed |
||||
|
Vries ST, Keers JC, Visser R, Zeeuw D, Haaijer-Ruskamp FM, Voorham J, Denig P (2014). Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J. Psychosom. Res. 76:134–138. crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
